J. Houghton

M. Baum, J. Houghton, R. Nissen-Meyer, 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Breast cancer trials--a new initiative.

M. Baum, J. Houghton, N. Kemp, 1980, British medical journal.

RESULTS OF THE CANCER-RESEARCH CAMPAIGN ADJUVANT TRIAL FOR PERIOPERATIVE CYCLOPHOSPHAMIDE AND LONG-TERM TAMOXIFEN IN EARLY BREAST-CANCER REPORTED AT THE 10TH YEAR OF FOLLOW-UP

K. McPherson, T. Wheeler, M. Baum, 1992 .

P99 Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer

M. Baum, J. Houghton, 1998 .

Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer.

J. Haybittle, M. Baum, R. A’Hern, 1989, BMJ.

Tamoxifen alone is not adequate treatment for most elderly patients with operable breast cancer

M. Baum, T. Bates, J. Houghton, 1992 .

The Cancer Research Campaign trials of adjuvant therapy for early breast cancer.

S. Ebbs, M. Baum, R. A’Hern, 1989, Acta oncologica.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer

J. Cuzick, A. Howell, J. Forbes, 2003, Cancer.

Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study.

J. Cuzick, M. Dowsett, C. Wale, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In reply [4]

J. Cuzick, M. Dowsett, A. Buzdar, 2006 .

Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. Current Trials working Party of the Cancer Research Campaign Breast Cancer Trials Group.

S. Cawthorn, M. Kissin, I. Smith, 1996, Journal of the National Cancer Institute.

Endometrial cancer during tamoxifen treatment

M. Baum, J. Houghton, W. Odling‐Smee, 1994, The Lancet.

Results of the Cancer Research Campaign Adjuvant Trial for Perioperative Cyclophosphamide and Long-Term Tamoxifen in Early Breast Cancer reported at the tenth year of follow-up. Cancer Research Campaign Breast Cancer Trials Group.

M. Baum, J. Houghton, D. Riley, 1992, Acta oncologica.

Early stopping rules--clinical perspectives and ethical considerations.

M Baum, M. Baum, J. Houghton, 1994, Statistics in medicine.

Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.

Jack Cuzick, Valerie Speirs, Mitch Dowsett, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of radiotherapy following total mastectomy for patients with early breast cancer

J. Haybittle, M. Baum, J. Houghton, 1985, World Journal of Surgery.

Social class and weight as prognostic factors in early breast cancer.

J. Haybittle, M. Baum, J. Houghton, 1997, British Journal of Cancer.

Adjuvant Radiotherapy in Breast Cancer: Consideration of Cost-Benefits in Relation to the CRC (King's/Cambridge) Trial

M. Baum, J. Houghton, 1989, International Journal of Technology Assessment in Health Care.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

J. Cuzick, J. Forbes, J. Klijn, 2002, The Lancet.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

M Baum, J Cuzick, J F Forbes, 2005, The Lancet.

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.

M. Dowsett, J. Farndon, J. Salter, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Late follow‐up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer

M. Baum, T. Bates, J. Houghton, 2004, The British journal of surgery.

0-70. The addition of surgery to tamoxifen as primary treatment of early breast cancer in women over 70, a multicentre trial

M. Baum, T. Bates, J. Houghton, 1997 .

INFORMED CONSENT AND CONTROLLED TRIALS

M. Baum, J. Houghton, H. Dudley, 1988, The Lancet.

Putting the risk of breast cancer in perspective

J. Bunker, M. Baum, J. Houghton, 1998, BMJ.

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial

J. Houghton, 2003, The Lancet.

Confirmed dissent and informed consent.

M. Baum, J. Houghton, M. Baum, 1993, European journal of cancer.

Is clinical breast examination an acceptable alternative to mammographic screening?

M. Baum, J. Houghton, H. Thornton, 2000, British medical journal.

Breast cancer in the elderly: Surgery improves survival. The results of a cancer research campaign trial

M. Baum, T. Bates, J. Houghton, 2001 .

Adjuvant Zoladex in premenopausal patients with early breast cancer: results from the ZIPP trial.

M. Baum, J. Houghton, W. Ea, 2001 .

Conventional Adjuvant Hormonal Therapy

M. Baum, J. Houghton, N. Williams, 2001 .

Ethics of clinical research: lessons for the future.

M. Baum, J. Houghton, K. Zilkha, 1989, BMJ.

Is informed consent essential for all chemotherapy studies?

J. Houghton, J. Tobias, 1994, European journal of cancer.

Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.

A. Thompson, M. Baum, J. Vaidya, 2006, International journal of radiation oncology, biology, physics.

Radiotherapy and tamoxifen in women with completely excided ductal carcinoma in suit

I. Ellis, J. Houghton, M. Spittle, 2003, The Lancet.

Prophylactic radiotherapy following surgery for early breast cancer - is the benefit mainly to patients with involved margins? Results from a Cancer Research Campaign Trial

M. Baum, J. Houghton, I. Potyka, 2001 .

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ

A. Pedotti, I. Fentiman, W. Tjalma, 2003, The Lancet.

Tamoxifen to prevent breast cancer

M. Baum, J. Houghton, Diana Riley, 1991, The Lancet.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

J. Cuzick, A. Howell, J. Forbes, 2005, The Lancet.

Intraoperative radiotherapy for breast cancer.

M. Baum, J. Vaidya, D. Joseph, 2004, The Lancet. Oncology.

RECRUITMENT TO BREAST CANCER TRIALS

R. Blamey, J. Houghton, C. Clark, 1984, The Lancet.

CURRENT AND FUTURE MANAGEMENT OF "EARLY" BREAST CANCER: ATTITUDE SURVEY AMONGST PARTICIPANTS IN CANCER RESEARCH CAMPAIGN TRIAL

M. Baum, J. Houghton, 1980, The Lancet.